ArticleOncotarget2017

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.

Carmine De Angelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.